C
Connect Biopharma Holdings Limited (CNTB)
NGM – Real vaqt narxi. Valyuta: USD
2.68
+0.34 (14.53%)
Yopilishda: May 12, 2026, 4:00 PM EDT
2.64
-0.04 (-1.49%)
Bozor oldidan: May 13, 2026, 7:31 AM EDT
Find any stock by ticker or company name

NGM – Real vaqt narxi. Valyuta: USD
2.68
+0.34 (14.53%)
Yopilishda: May 12, 2026, 4:00 PM EDT
2.64
-0.04 (-1.49%)
Bozor oldidan: May 13, 2026, 7:31 AM EDT
Connect Biopharma Holdings Limited Qo'shma Shtatlarda klinik bosqichdagi biofarmatsevtika kompaniyasi sifatida faoliyat yuritadi. Kompaniya astma va surunkali obstruktiv o'pka kasalligining (COPD) o'tkir zo'rayishlarini davolash uchun ikkita 2-bosqichli tadqiqotda IL-4Rα ga qarshi yo'naltirilgan inson monoklonal IgG4 antitelasi bo'lgan rademikibartni ishlab chiqadi. Kompaniya 2012-yilda tashkil etilgan va uning shtab-kvartirasi San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Barry D. Quart Pharm.D. | CEO & Director |
| Dr. Lei Sun Ph.D. | VP of Biologics & Head of CMC |
| Dr. Srikanth Pendyala M.D. | Senior Vice President of Clinical Development(Consultant) |
| Mr. David L. Szekeres J.D. | President |
| Mr. Jeff Cohn J.D. | General Counsel & Corporate Secretary |
| Mr. Sean T. Ristine | Vice President of Human Resources |
| Ms. Kimberly J. Manhard | Executive VP & Chief Development Officer |
| Ms. Lisa Peraza CPA | Senior Vice President of Finance |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-23 | 8-K | cntb-20260423.htm |
| 2026-03-31 | 8-K | cntb-20260331.htm |
| 2026-03-31 | 10-K | cntb-20251231.htm |
| 2026-03-30 | 8-K | cntb-20260329.htm |
| 2025-12-23 | 8-K | cntb-20251217.htm |
| 2025-11-12 | 10-Q | cntb-20250930.htm |
| 2025-09-16 | 8-K | cntb-20250916.htm |
| 2025-09-10 | POS AM | d94748dposam.htm |
| 2025-08-13 | 8-K | cntb-20250813.htm |
| 2025-08-13 | 10-Q | cntb-20250630.htm |